IBD0333
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IBD0333, covering 2025-01-17 to 2025-01-17. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial to Evaluate Effect of IBD0333 in Patients With Advanced Malignant Tumors [Phase 1, Phase 2]